Cargando…

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

BACKGROUND: N-lactosyl-dioleoylphosphatidylethanolamine (Lac-DOPE) was synthesized and evaluated as a liver-specific targeting ligand via asialoglycoprotein receptors for liposomal delivery of doxorubicin. METHODS: Lactosylated liposomes encapsulating calcein (Lac-L-calcein) or doxorubicin (Lac-L-DO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaoju, Zhang, Mengzi, Yung, Bryant, Li, Hong, Zhou, Chenguang, Lee, L James, Lee, Robert J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476751/ https://www.ncbi.nlm.nih.gov/pubmed/23093902 http://dx.doi.org/10.2147/IJN.S33965

Ejemplares similares

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin
por: Teran-Saavedra, Nayelli Guadalupe, et al.
Publicado: (2020)

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
por: Bian, Yun, et al.
Publicado: (2020)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei, Minyan, et al.
Publicado: (2015)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma
por: Teran-Saavedra, Nayelli Guadalupe, et al.
Publicado: (2019)

Thermally-Induced Lactosylation of Whey Proteins: Identification and Synthesis of Lactosylated β-lactoglobulin Epitope
por: Gasparini, Alessandra, et al.
Publicado: (2020)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
por: Schmidinger, M, et al.
Publicado: (2001)

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Xia, Yu, et al.
Publicado: (2019)

MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
por: Xu, Fei, et al.
Publicado: (2017)

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
por: Fan, Yin-Ping, et al.
Publicado: (2017)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
por: Valle, J W, et al.
Publicado: (2005)

Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015)

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
por: Zheng, Yanwen, et al.
Publicado: (2021)

Reduction of polyethylenimine-coated iron oxide nanoparticles induced autophagy and cytotoxicity by lactosylation
por: Du, Jiuju, et al.
Publicado: (2016)

Lactosylated IR820/DOX Co-Assembled Nanodrug for Synergetic Antitumour Therapy
por: Jiang, Yue, et al.
Publicado: (2020)

Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin
por: Zhao, Chen, et al.
Publicado: (2013)

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
por: Akache, Bassel, et al.
Publicado: (2023)

Hepatocyte-Specific Co-Delivery of Zinc Ions and Plasmid DNA by Lactosylated Poly(1-vinylimidazole) for Suppression of Insulin Receptor Internalization
por: Endo, Akito, et al.
Publicado: (2021)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Mannosylated liposomes for targeted gene delivery
por: Kong, Fansheng, et al.
Publicado: (2012)

Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma
por: Sarfraz, Muhammad, et al.
Publicado: (2017)

Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma
por: Rahim, Muhammad Abdur, et al.
Publicado: (2021)

A Mathematical Model for Thermosensitive Liposomal Delivery of Doxorubicin to Solid Tumour
por: Zhan, Wenbo, et al.
Publicado: (2013)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Lactosylated N-Alkyl polyethylenimine coated iron oxide nanoparticles induced autophagy in mouse dendritic cells
por: Shen, Taipeng, et al.
Publicado: (2018)

One-Step Microfluidic Fabrication of Multi-Responsive Liposomes for Targeted Delivery of Doxorubicin Synergism with Photothermal Effect
por: Lv, Songwei, et al.
Publicado: (2021)

Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization
por: Nie, Yu, et al.
Publicado: (2012)

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
por: Duan, Wendu, et al.
Publicado: (2018)

Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy
por: Wang, Wen-Yan, et al.
Publicado: (2019)

Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects
por: Zhao, Xiaoli, et al.
Publicado: (2023)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
por: Kullenberg, Fredrik, et al.
Publicado: (2021)

Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity
por: Wang, Wenxi, et al.
Publicado: (2017)

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
por: Lian, Bo, et al.
Publicado: (2021)

A Polyethylenimine-Linoleic Acid Conjugate for Antisense Oligonucleotide Delivery
por: Xie, Jing, et al.
Publicado: (2013)

Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug-Specific Parameters in Local Delivery to Tumors
por: Hendriks, B S, et al.
Publicado: (2012)

Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy
por: Wu, Cheng-Der, et al.
Publicado: (2019)

Co-delivery of doxorubicin and itraconazole by Pluronic® P123 coated liposomes to enhance the anticancer effect in breast cancers
por: Lin, Yi, et al.
Publicado: (2018)

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
por: O’Donnell, Robert T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_n62o5li12ds9bv5ls53l4fcsqe